|

Silmitasertib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CX-4945

Pipeline

Phase 1/2: 1

Top Sponsors

  • Milton S. Hershey Medical Center1

Indications

  • Liposarcoma1
  • Neuroblastoma1
  • Osteosarcoma1
  • Rhabdomyosarcoma1
  • Ewing Sarcoma1

Birmingham, Alabama1 trial

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

University of Alabama/Children's of Alabama

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.